Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

NexLife vs Options Medical Weight Loss

NexLife
Graded #147

Higher grade

vs+3
Options Medical Weight Loss
Graded #223

Lower grade

The verdict

NexLife takes it — 68.5/100 to 65.5/100.

NexLife grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NexLife is a LegitScript-certified telehealth platform offering compounded semaglutide (from $145/mo) and compounded tirzepatide (from $186/mo).

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNexLife +16
70
54
Dose & formulationOptions Medical Weight Loss +13
64
77
Clinical oversightNexLife +8
89
81
Labs & monitoringEven
53
53
FulfillmentEven
67
67
Contract termsEven
55
55
NexLife · left barOptions Medical Weight Loss · right bar

The numbers

MetricNexLifeOptions Medical Weight Loss
WeighScore68.5/10065.5/100
GradeCC
Scorecard rank#147#223
Semaglutide$165/mo (compounded)$199/mo (compounded)
Tirzepatide$215/mo (compounded)$399/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
NexLife

Graded #147 · C

Strengths

  • LegitScript certified platform
  • Works exclusively with LegitScript-certified, NABP-accredited pharmacies — strongest pharmacy trust signal in the dataset
  • Both semaglutide and tirzepatide at competitive pricing
  • Semaglutide from $145/mo on the 12-month plan ($165/mo month-to-month) - among the lowest in the dataset

Where it loses points

  • State availability not publicly disclosed
  • Compounded only — no brand-name options
  • Also covers hormone optimization and longevity
  • Lowest advertised rates ($145 sema / $186 tirz) require a 12-month plan commitment

Strengths

  • LegitScript certified with clear, upfront program pricing
  • Compounded semaglutide (~$239) and tirzepatide (from $299), plus NAD+
  • Structured metabolic-health program with provider support and accountability
  • HSA/FSA eligible with flexible payment options

Where it loses points

  • Doesn't clearly publish which states its telehealth covers
  • Tirzepatide tiers climb to $339-$399/month
  • More program structure (and cost) than medication-only sellers
  • Compounded GLP-1 only online — no brand-name options noted

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard